Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications
Biotechnology Progress – October 04, 2024
Source: OpenAlex
Summary
Psychedelics and Drug Studies reveal psilocybin, a potent tryptamine, holds immense promise for treating depression and anxiety. Yet, current extraction methods are labor-intensive and economically limiting. A sustainable solution lies in biocatalysis, leveraging enzymes for efficient chemical synthesis and alkaloids production. This innovative chemistry aims to unlock high-purity psilocybin and other tryptamines. Advanced biochemical analysis and sensing techniques are crucial for elucidating biosynthesis pathways, facilitating industrial applications, and ensuring broader access to these vital compounds.
Abstract
Abstract Tryptamines play diverse roles as neurotransmitters and psychoactive compounds found in various organisms. Psilocybin, a notable tryptamine, has garnered attention for its therapeutic potential in treating mental health disorders like depression and anxiety. Despite its promising applications, current extraction methods for psilocybin are labor‐intensive and economically limiting. We suggest biocatalysis as a sustainable alternative, leveraging enzymes to synthesize psilocybin and other tryptamines efficiently. By elucidating psilocybin biosynthesis pathways, researchers aim to advance synthetic methodologies and industrial applications. This review underscores the transformative potential of biocatalysis in enhancing our understanding of tryptamine biosynthesis and facilitating the production of high‐purity psilocybin and other tryptamines for therapeutic and research use.